Adamis Announces Agreement to Sell Portion of US Compounding Business
August 04, 2021 16:05 ET
|
Adamis Pharmaceuticals Corporation
SAN DIEGO, Aug. 04, 2021 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today announced that it has entered into a definitive agreement to sell a significant portion of the...
Adhera Signs Definitive License Agreement with Melior Pharmaceuticals II for New Parkinson’s Disease Drug Candidate
July 29, 2021 09:00 ET
|
Adhera Therapeutics, Inc.
Adhera to develop MLR-1019 (armesocarb) as a new class of drug for Parkinson’s Disease (PD), representing the only drug to address both movement and non-movement symptoms of PDArmesocarb is the active...
Nutra Pharma Provides Business and Compliance Updates
July 26, 2021 10:30 ET
|
Nutra Pharma Corp.
Plantation, Florida, July 26, 2021 (GLOBE NEWSWIRE) -- Nutra Pharma Corporation (OTC Pink: NPHC), a biotechnology company marketing Nyloxin®, Pet Pain-Away™, Luxury Feet™ and Equine Pain-Away™ in...
Nutra Pharma Files Updated Provisional Patent for Nerve Agent Counter Measures
July 23, 2021 09:14 ET
|
Nutra Pharma Corp.
Plantation, Florida , July 23, 2021 (GLOBE NEWSWIRE) -- Nutra Pharma Corporation (OTC Pink: NPHC), a biotechnology company marketing Nyloxin®, Pet Pain-Away™, Luxury Feet™ and Equine Pain-Away™ in...
Inotiv Acquires Laboratory Instrumentation for Discovery and Development of Novel Therapies
July 15, 2021 08:33 ET
|
Inotiv, Inc.
WEST LAFAYETTE, Ind., July 15, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and...
Nutra Pharma Engages Government Affairs Consulting Firm
July 15, 2021 08:30 ET
|
Nutra Pharma Corp.
Plantation, Florida, July 15, 2021 (GLOBE NEWSWIRE) -- Nutra Pharma Corporation (OTC Pink: NPHC), a biotechnology company marketing Nyloxin®, Pet Pain-Away™, Luxury Feet™ and Equine Pain-Away™ in...
Biofrontera reports preliminary revenue for the month of June 2021
July 06, 2021 10:00 ET
|
Biofrontera AG
Leverkusen, Germany, July 06, 2021 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today reported...
PAOG Targets $18 Billion Market Opportunity With New CBD Nutraceutical To Be Packaged By ALKM And Marketed By USMJ
June 24, 2021 09:00 ET
|
PAO Group, Inc.
Sandusky, Ohio, June 24, 2021 (GLOBE NEWSWIRE) -- PAO Group, Inc. (OTC Pink: PAOG) today published a CBD Nutraceuticals Business Development Update. PAOG expects to generate revenue this year from...
Solvent Evaporation Market to Outstrip $821.41 Million by 2028 Growing Sturdy at 6.7% CAGR - COVID-19 Impact and Global Analysis by TheInsightPartners.com
June 22, 2021 13:25 ET
|
The Insight Partners
Pune, India, June 22, 2021 (GLOBE NEWSWIRE) -- Solvent Evaporation Market: Key InsightsAccording to our new research study on “Solvent Evaporation Market to 2028 – Global Analysis and Forecast – by...
PAOG Confirms CBD Nutraceuticals Business Development Update To Include ALKM, USMJ and PURA Highlights Scheduled This Wednesday, June 23rd
June 21, 2021 10:35 ET
|
PAO Group, Inc.
Sandusky, Ohio, June 21, 2021 (GLOBE NEWSWIRE) -- PAO Group, Inc. (OTC Pink: PAOG) today confirmed a CBD Nutraceuticals Business Development Update scheduled for release this week, on Wednesday,...